Tokyo, Japan (April 03, 2023) - Evident Corporation, a leading provider of imaging, instrumentation, and measurement solutions, has been acquired by Bain Capital Private Equity from Olympus Corporation. The definitive agreement, signed on August 29, 2022, has paved the way for Evident's transformation into an independent entity headquartered in Tokyo, Japan, with over 4,300 employees across 24 countries worldwide.
Evident is poised for accelerated growth in the life science and industrial markets, with Bain Capital's backing for agility, faster decision-making, and innovation. Leveraging its rich heritage of more than 100 years of technological innovation, Evident plans to broaden its portfolio of world-class products, solutions, and services.
Yoshitake Saito, President and CEO of Evident said, "We are thrilled about our partnership with Bain Capital, which will strengthen our commitment to becoming the go-to workflow solution partner for a broad range of customers in the life science and industrial markets."
Yuji Sugimoto, Partner of Bain Capital in Japan, affirmed Bain Capital's commitment to support Evident on a sustainable growth path, to foster an accelerated innovation process. Stephen Thomas, Partner of Bain Capital in North America, added that Evident has great potential to expand into new products, customers, and markets as an independent company.
Evident is guided by the scientific spirit of innovation and exploration, working towards making people's lives healthier, safer, and more fulfilling. The company's solutions range from microscopes and videoscopes to nondestructive testing equipment and X-ray analyzers for maintenance, manufacturing, and environmental applications. In the life sciences sector, Evident offers a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications, as well as for research and education.
About EVIDENT
EVIDENT is driven by the scientific spirit of innovation and exploration, striving to enhance people's lives and make them healthier, safer, and more fulfilling. By providing innovative solutions that tackle customers' challenges, we help them advance their work, whether conducting medical research, inspecting infrastructure, or uncovering hidden toxins in consumer products.
EVIDENT Industrial specializes in various cutting-edge solutions, from microscopes and videoscopes to non-destructive testing equipment and X-ray analyzers for maintenance, manufacturing, and environmental applications. Our state-of-the-art technologies and products are widely used for quality control, inspection, and measurement.
EVIDENT Life Science empowers scientists and researchers through collaboration and cutting-edge life science solutions. We strive to meet our customers' evolving needs and challenges by providing a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications, as well as for research and education purposes.
For more information, visit evidentscientific.com
About Bain Capital Private Equity
Bain Capital Private Equity, established in 1984, has a strong history of partnering with management teams to help build and grow successful companies. With over 280 investment professionals globally, Bain Capital Private Equity provides its portfolio companies with access to strategic resources and expertise in key industries, such as healthcare, consumer/retail, financial and business services, industrials, technology, media, and telecommunications.
With offices in 23 locations across four continents, Bain Capital has made primary or add-on investments in more than 1,100 companies. The firm invests in private equity across multiple asset classes, including credit, public equity, venture capital, and real estate. Bain Capital manages approximately $160 billion in assets, leveraging the shared platform to identify and capture opportunities in strategic areas of focus.
For more information, please visit www.baincapitalprivateequity.com
